VAN ECK ASSOCIATES CORP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$19,775
+19.7%
1,278,300
+21.6%
0.04%
+19.4%
Q2 2023$16,520
-1.4%
1,051,546
+3.4%
0.04%
-5.3%
Q1 2023$16,758
-39.8%
1,016,855
-43.0%
0.04%
-47.2%
Q4 2022$27,849
-99.9%
1,785,206
-4.1%
0.07%0.0%
Q3 2022$24,150,000
-13.6%
1,862,022
-6.4%
0.07%
-2.7%
Q2 2022$27,936,000
+73.1%
1,989,772
+76.5%
0.07%
+124.2%
Q1 2022$16,143,000
+2.6%
1,127,270
-2.3%
0.03%
-8.3%
Q4 2021$15,730,000
+10.0%
1,154,076
+32.2%
0.04%0.0%
Q3 2021$14,294,000
+36.3%
872,651
+40.1%
0.04%
+44.0%
Q2 2021$10,485,000
+2.0%
622,965
+10.7%
0.02%
-10.7%
Q1 2021$10,276,000
-6.9%
562,734
-7.3%
0.03%
-12.5%
Q4 2020$11,043,000
-47.4%
606,778
-48.5%
0.03%
-3.0%
Q3 2020$21,004,000
+4.4%
1,177,396
+5.0%
0.03%
-5.7%
Q2 2020$20,112,000
+171.4%
1,121,718
+129.8%
0.04%
-7.9%
Q1 2020$7,410,000
-15.2%
488,111
+10.2%
0.04%
+11.8%
Q4 2019$8,743,000
+36.3%
443,112
+18.8%
0.03%
+13.3%
Q3 2019$6,415,000
-17.5%
372,972
-15.1%
0.03%
-18.9%
Q2 2019$7,776,000
-6.6%
439,339
+7.5%
0.04%
-9.8%
Q1 2019$8,323,000408,5880.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders